Lonza Group AG

Lonza Group AG, founded in 1897, is a Swiss multinational company specializing in contract development and manufacturing services for the pharmaceutical, biotechnology, and nutrition industries. Headquartered in Basel, Switzerland, Lonza operates over 30 sites across Europe, North America, and Asia, employing approximately 18,000 people. The company offers a comprehensive range of services, including the development and manufacturing of biopharmaceuticals, small molecules, cell and gene therapies, and health ingredients. Lonza's mission is to transform customers' breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. The company is recognized as a pioneer and world leader in the contract development and manufacturing organization (CDMO) industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. In 2023, Lonza reported revenues of CHF 3.6 billion and a CORE EBITDA of CHF 1.1 billion.